Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment.

Antonio M de, A Galán, J Vila, A Urrutia, A Bayes-Genis, Jose Lupon Roses, Elisabet Zamora Serrallonga

Research output: Contribution to journalArticleResearch

47 Citations (Scopus)
Original languageEnglish
Pages (from-to)243-43
JournalMayo Clinic Proceedings
Issue number3
Publication statusPublished - 1 Jan 2013

Cite this